Analysts at Citi have expressed bearish sentiments on the shares of Commonwealth Bank of Australia (ASX:CBA), asserting that they are traded at a substantial premium compared to its counterparts and the broader market.

The shares of the Australia’s number one lender is presently A$104.850, compelling the brokerage house to keep its ‘sell’ rating on the bank and maintain a price target of A$82.50.

The Commonwealth Bank of Australia announced a record annual cash profit of A$10.16 billion on Wednesday, prompting an increase in shares by 2.6%.

Citi suggests that the first half of 2023 bore most of the burden, identifying signs of deterioration in the second half which the bank didn’t address in detail.

It predicts that the bank could venture into sub-system volume growth into the financial year 2024; the bank had recorded a 5.0% surge in home lending volumes in the financial year 2023 versus a 4.9% growth in the Australian banking system.

Out of 15 analysts, four recommend ‘hold’ for the bank’s stock while eleven suggest a ‘sell’, with a median price target of A$87.60, according to Refinitiv data.

The Commonwealth Bank of Australia is the largest lender in Australia.

Citi’s analysts are projecting a 3% increase in earnings before interest and taxes (EBIT) for Australia’s Lottery Corp (ASX:TLC) in FY23.

The potential earnings growth is envisaged to total A$623 million.

The firm’s estimation for the FY24 EBIT remains significantly higher than most, standing 9% above consensus.

Citi maintains its optimistic outlook due to the increased revenue from alterations to the Oz Lotto platform and higher prices for Powerball tickets.

The brokerage maintains a ‘buy’ rating for the stock and expects a per share price target of A$5.70.

Of 15 analysts who rated the stock, seven recommended to ‘buy’ or rate higher, seven suggested to ‘hold’, and one regards it as a ‘strong-sell’, with a median price target of A$5.55.

Additionally, Lottery Corp’s stock has appreciated 18.3% this year up to the recent market close.

Lottery Corp is an Australian-based company specializing in various lottery and gambling services.

Citi’s analysts lift their price target for Australia’s Suncorp Group (ASX:SUN) to A$15.40/share from A$14.90/share.

The company sees a notable 12.6% increase in gross written premium in the second half which bodes well for future periods, according to the brokerage.

Suncorp Group (ASX:SUN) reported an impressive 86.3% rise in fiscal year cash earnings this Wednesday, primarily due to top-line growth across the group.

Citi points out the company’s expanding top-line growth as a prominent feature of its fiscal 2023 result, suggesting the momentum is likely to carry on into fiscal year 2024.

The firm believes that the acceleration in top-line metrics and key margins could expand beyond the first half of fiscal 2024.

Everyone among the 12 analysts covering the stock rates ‘buy’ or higher with a median price target of A$14.95.

This year, the stock has seen a 12.5% increase, as per the last close.

Suncorp Group (ASX:SUN) is a leading financial services conglomerate in Australia providing both insurance and banking services.

Beauty Health Company (ASX:SKIN) shares declined 1.5%, falling to $7.4.

The beauty tech company responsible for producing skin treatment devices made the decision to withdraw their gross margin forecast for the fiscal year of 2023 due to margin difficulties experienced in Q2 extending into the second half.

On a separate note, Michael Monahan has been confirmed as the new chief financial officer, assuming his role from August 10.

He replaces Liyuan Woo, who will remain as an advisor until September 1, 2023, to facilitate a smooth transition.

Beauty Health reported net sales of $117.5 million in Q2, surpassing estimates of $116.09 million according to Refinitiv.

The Q2 EPS was 3 cents per share, marking an improvement from the loss of 6 cents per share recorded in the previous year.

Despite this, Beauty Health maintains their 2023 net sales forecast citing consistent demand for their Hydrafacial product and robust trends in the Chinese market.

The company also reiterated their long-term financial forecast for 2025.

Amongst 12 brokerages, seven rated the stock as ‘buy’ or higher, four recommended ‘hold’, with a median price target of $15.00.

Including the latest market activity, the company’s stock has seen a decline of 19.40% year-to-date.

Beauty Health is a highly regarded producer of skin treatment devices and other beauty technologies.

Flutter Entertainment (ASX:FLTRF) shares fell 4.4% to 144.05 pounds, making them among the top percentage losers on the FTSE bluechip index.

Despite posting a 76% increase in half-year core profit, the world’s largest online betting firm warned of a weakening Australian market outlook.

The U.S.

market saw the company’s core profit swing to 49 million pounds from a loss of 132 million compared to the previous year, due, in large part, to a strong performance from the Fanduel brand.

Flutter Entertainment cautioned investors on softer-than-expected demand in the Australian market, where half-year profits fell by 27% owing to strong COVID-related comparatives and a changing tax environment.

Despite this, J.P.Morgan has cited that the strong H1 was partly offset by a cautious outlook on Australia, where lower market growth expectations could impact Sportsbet profitability.

Contrarily, Jefferies believes that the impact of the Australian soften may be negated by robust UK and international markets.

Flutter Entertainment shares are at their lowest since March 29.

As of the last close, the stock has risen about 32% so far this year.

Flutter Entertainment is the world’s largest online betting firm.

Shares of Octava Minerals experience a rise as high as 6.3% to A$0.085, marking its highest level since July 26.

Octava Minerals, a metals explorer, reports that sampling from the Yallalong project in Western Australia has unveiled possible nickel, copper, and cobalt ores.

The company also indicates that efforts towards acquiring heritage clearance, which would enable drilling, are currently underway.

Despite the recent uplift, the stock had fallen 33.3% this year as of the last close.

Octava Minerals (ASX:OCT) is a metals explorer that primarily focuses on the extraction of nickel, copper, and cobalt ores.

Shares of West Cobar Metals (ASX:WC1) experience a significant increase of 81.3%, reaching A$0.145 per share, the peak value seen since March 30.

The surge is attributed to its announcement that the mineral resource at its Salazar clay hosted rare-earths element (REE) project located in Western Australia has quadrupled.

Furthermore, West Cobar Metals (ASX:WC1) states that the amplified resources are the result of the recently initiated Phase I air core drilling programme.

As a result, approximately 7.4 million shares were traded - almost 90 times higher than the 30-day average trading volume of 82,348 shares.

Despite this considerable increase, West Cobar Metals (ASX:WC1)’s year-to-date performance remains on the downside, revealing a decline of 52.9% as of the market’s last close.

West Cobar Metals (ASX:WC1) is a company that mainly engages in mineral exploration, specifically on projects based in Western Australia.

Commonwealth Bank of Australia (ASX:CBA) sees a rise of up to 2.9% to A$105.22, marking its most significant intraday gain since October 2022.

The bank has announced a record annual cash profit of A$10.16 billion, a 6% increase from the previous year.

Additionally, it unveiled a final dividend of A$2.40 per share, taking the total dividend to a record A$4.50 per share.

However, the bank has warned of potential headwinds affecting margins in FY24 due to stiff competition in home loans and rising costs, although these risks could be partly offset by higher interest rates.

Commonwealth Bank of Australia has sealed its place among the top five gainers in the ASX 200 benchmark index, reaching its highest level since August 2.

Citi notes that the bank has sought to portray strength and stability in its FY23 disclosures, anticipating that supportive metrics will boost the stock’s defensiveness in the current environment.

The bank’s shares are marginally down this year, as of the latest close, compared to a 0.4% rise in the ASX 200 Financials index.

Commonwealth Bank of Australia (ASX:CBA) is a leading Australian bank offering a variety of financial services, including retail, business and institutional banking, funds management, superannuation, insurance, investment, and broking services.

Shares of biopharmaceutical company Immuron (ASX:IMC) experienced a significant rise, as much as 27% to A$0.094, marking their largest intraday jump since May 9.

The surge came after Immuron received Good Manufacturing Practice clearance from the Therapeutic Goods Administration (TGA).

This clearance allows the company to release and dispatch Travelan, its oral immunotherapeutic drug utilised in the treatment of travellers' diarrhoea, to customers within this week.

According to the company, Immuron’s resolution of supply and stock outages will facilitate the anticipated growth in sales within Australia.

The clearance led the stock to reach its highest level since May 15.

On the day of the announcement, over 746,000 shares changed hands, a substantial increase compared to the 30-day average of about 198,000 shares.

However, as of the last close, the stock had declined by roughly 14% year to date.

Immuron is a biopharmaceutical company that specializes in the development and commercialisation of oral immunoglobulin therapeutics for the treatment of gut mediated diseases.

Perpetual Resources (ASX:PEC) shares experienced an impressive upswing, increasing by as much as 68.2% to A$0.037, the highest level recorded since September 12, 2022.

This significant surge followed the company’s acquisition of three exploration permits.

These permits cover 5,000 hectares of land within the Minas Gerais region in Brazil, an area known for its abundance of hard-rock lithium spodumene deposits.

In a parallel development, Perpetual Resources (ASX:PEC) also secured commitments to raise A$1.5 million through a share placement at A$0.022 per share, matching its last closing price.

This financial activity occurred alongside a surge in trading volumes, which reached seven times the 30-day average of 6.1 million shares.

The year-to-date rise of Perpetual Resources (ASX:PEC) shares stands at 22.2%, measured at the last close.

Perpetual Resources is a mineral exploration company focusing on the acquisition, exploration, and development of lithium and other mineral resource projects.